Built for growth, valuation, and exit outcomes

We work with founders, executive teams, and private equity operators who already have strong businesses. And they need those businesses to be understood, trusted, and valued by buyers.

Legacy DNA is a growth partner for mid-market healthtech and pharmacy companies operating under real enterprise value pressure.

Book a Strategic Fit Call

Person using a laptop with digital analytics and KPI data overlays on the screen.

Every business has a commercial DNA. Most companies never fully unlock the value within it.

Legacy DNA refers to the underlying commercial structure that explains why a business works and whether that value can travel beyond the founder, the current team, or a single growth phase.

Our work lives at the intersection of growth, credibility, and transferability. We focus on what buyers care about, how value is created, and whether it will hold up under scrutiny.

Founded by Dr. Roxie Mooney‍ ‍

Rocket launching into space with stars and clouds in the background

OUR MISSION

To help mid-market healthcare leaders build commercial systems that translate growth into enterprise value that lasts — beyond a single growth phase, a single leader, or a single transaction.

Icon of an eye inside a clock face, symbolizing eye care or vision monitoring.

OUR VISION

A healthcare ecosystem where companies capable of improving lives reach the scale and valuation they deserve — because they were built, positioned, and valued to endure.

16+ years. Four successful exits.
One repeatable approach.

$750M → $2B

BioPlus scaled to two acquisitions

$50M → $500M

Mid-market healthtech trajectories guided

100+

Healthcare/healthtech product launches supported

"Roxie didn't just observe from the edges. She helped us translate complexity into clarity and made sure the decisions we were making supported not just the next quarter, but what the company would be worth when it was time to hand it to someone else."

— Mark Montgomery, Former CEO, BioPlus Specialty Pharmacy

Six women photographed in individual circular frames, smiling and looking at the camera.

Senior-led. Not delegated.

Legacy DNA is a small, senior-led firm. We work with a limited number of companies each year — by design. Every engagement is led directly by Dr. Roxie Mooney and senior team members with direct healthcare exit experience. There is no junior handoff, no account management layer, and no project team you haven't met.

Enterprise healthcare ‍ ‍ Regulated environments ‍ ‍ Board-level communications ‍ ‍ PE-backed execution

Speed. Clarity. Impact.

We recognize our clients are running businesses. They don't have time for long intake processes, weekly status meetings, or deliverables that take six weeks to produce a first draft. Our process is designed for the pace of a scaling company: rapid diagnostic, clear scoping, weekly working sessions, and deliverables that arrive ready to use.

Rapid diagnostic

Clear scoping

Weekly working sessions

Deliverables ready to use

A scientific or technological infographic with a stylized human head silhouette and DNA helix, surrounded by gear and circuit icons, labeled with phrases such as "Strategic Fit Call," "Your Personalized Analysis," "Exit Readiness Score," and "Vision, Impact, and Value Creation."

YOUR NEXT STEP

Schedule your Strategic Fit Call

A 45-minute conversation with Dr. Roxie Mooney. We’ll talk through where growth might be breaking, what the pattern looks like, and whether a deeper engagement makes sense.

No pitch. No pressure. Just clarity.